Case Study 08G ;
Ginseng Green Red Bio Metabolome
Challenges to Address:
Overcoming the human side effects, low absorption rate, irregular production yield, low functionality, user limitations, and biological issues associated with the pharmacological compounds (ginsenosides) found in ginseng.
Solution:
Inducing an ecological transformation by combining the common ginsenosides found in ginseng with the unique and rare ginsenosides present in 300-year-old wild ginseng..
Caution:
Chemical transformation may result in more severe cellular toxicity issues.
STEP 1 :
Inside the bio-metabolic process, the VPMI-CM Green Red Biocatalyst material induces changes in the microbial composition of ginseng.
STEP2:
The ginseng microbes acquire the genetic traits required for cellular metabolism through miRNA-based genetic information exchange. The microbes that acquire these new genetic traits are named Ginseng Vital Probiotics.
STEP3:
The Ginseng Vital Probiotics produce a new bio-material, the Ginseng Green Red Bio Metabolome, which is suitable for human cells through biological metabolic processes.
In the bio-metabolic system, a new microbial community generated by the VPMI-CM Green Red Biocatalyst metabolizes ginseng cells to produce the Ginseng Green Red Bio Metabolome. During this process, not only does the microbial composition change, but the composition of ginsenosides, the pharmacological components of ginseng, is also altered. Among the resulting metabolites, Ginsenoside M12 (PPDol) exhibits an additional function of neutralizing the toxicity of other pharmacological components.
"Rare Saponin"
"General Saponin"
"Unique Saponin"